N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
about
Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteineReciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosisTransforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer ProgressionRas promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cellsTime-dependent and somatically acquired mitochondrial DNA mutagenesis and respiratory chain dysfunction in a scleroderma model of lung fibrosisRadical-containing ultrafine particulate matter initiates epithelial-to-mesenchymal transitions in airway epithelial cellsEpidemiology and management of common pulmonary diseases in older personsEnvironmental particulate (PM2.5) augments stiffness-induced alveolar epithelial cell mechanoactivation of transforming growth factor betaWorkshop on idiopathic pulmonary fibrosis in older adultsInteractions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).Sulforaphane prevents bleomycin‑induced pulmonary fibrosis in mice by inhibiting oxidative stress via nuclear factor erythroid 2‑related factor‑2 activation.Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells.Respiratory syncytial virus inhibits ciliagenesis in differentiated normal human bronchial epithelial cells: effectiveness of N-acetylcysteine.Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transitionAstragalin inhibits autophagy-associated airway epithelial fibrosis.Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition.Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemiaDouble-Blind Randomized Trial of Pirfenidone in Chinese Idiopathic Pulmonary Fibrosis PatientsMolecular and cellular mechanisms of pulmonary fibrosis.Metabolic Reprogramming Is Required for Myofibroblast Contractility and Differentiation.The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibrosis.IL-17 induces type V collagen overexpression and EMT via TGF-β-dependent pathways in obliterative bronchiolitis.Hyperoxia induces alveolar epithelial-to-mesenchymal cell transition.Inhibition of epithelial-to-mesenchymal transition and pulmonary fibrosis by methacyclineThe pathogenesis of idiopathic pulmonary fibrosis.TGF-β: Titan of Lung Fibrogenesis.Mesenchymal stem cells protect from hypoxia-induced alveolar epithelial-mesenchymal transition.Protective Role of N-Acetylcysteine on Isoprenaline-Induced Myocardial Injury: Histological, Immunohistochemical and Morphometric Study.Directing epithelial to mesenchymal transition through engineered microenvironments displaying orthogonal adhesive and mechanical cues.Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation.Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-β1-induced epithelial-to-mesenchymal transition and cell migration.Oxidant-induced autophagy and ferritin degradation contribute to epithelial-mesenchymal transition through lysosomal iron.Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.The main actors involved in parasitization of Heliothis virescens larva.Assessment of the effect of potential antifibrotic compounds on total and αVβ6 integrin-mediated TGF-β activation.Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial.Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways.Fibroblasts that resist cigarette smoke-induced senescence acquire profibrotic phenotypes.The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial.Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions.
P2860
Q26777928-D8DF1A44-1059-4C09-A8D2-C00D4E6844E9Q26779846-F4DB9500-EB5E-4349-8967-47FD567DBB5DQ28083526-B707FFDA-439B-43F2-8570-1B0B9DC6AFB5Q28243232-9CDBC0E2-ED7F-4657-9A94-7B4C567E2A86Q28388130-D0BC421A-16F1-4EA0-8276-E17EF3798760Q28395979-EEAEE782-F023-4DA0-93F0-37A8E38FFBA8Q28397465-F732C449-FF11-4D5D-99D7-0E48C894D22EQ28543011-86AF3D04-9A1D-4D9B-8318-76A0CEFC4AC5Q28603445-E1282EF3-75AE-4C40-93EE-B35BF55E6F12Q30422043-4FB0705F-A4CD-41BD-AC24-64C2623B598CQ33702024-9C40BE23-2ECF-4B34-8687-4304B8C4A949Q33799283-ED959811-C536-4D04-9923-4D77C5D12782Q34464738-006A7EDC-C6EC-4A87-A2DD-4736E1EB4110Q34623170-BBB5EB14-4243-4D11-925C-B700A950B22BQ35523153-B8EBBFF2-05E6-4B5F-B1F1-5B89674DD3AAQ35641181-858F43D9-5B02-4C86-9591-D7AB67CAA688Q35821693-FABFD386-52EE-4ECC-A679-129AF413A6FDQ36207187-79508CC5-6D5A-49BC-A289-843DD41F882CQ36237168-A912BC0B-01D1-40E0-8BF4-6CC96EF35699Q36283317-0653CF13-C9A9-4006-9DA3-E6B6BA129763Q36652097-2CE9FBE3-6094-4EA7-A4FB-F04F87316914Q36699993-AC84185E-CC27-4F6E-9C16-714BDF6F35DBQ37576118-7C998987-4329-42B9-BD63-944AD64ACA6CQ37596095-4D1685EE-CA9C-42AB-A53A-7184C1D940C1Q37800756-EB9E6B27-008F-4EC0-8B6F-81D245E2191BQ38159689-E254E4AC-5488-477A-991C-E8E24088D54DQ38809230-FEA69CF9-4309-4E4E-B3B7-12B16336F496Q38821710-A200EE84-4F57-4DCA-9AF8-29B1A5FC2323Q39344618-CD750F7F-ED9B-4694-87A7-73508B649C21Q39395460-3505403A-28BE-44C4-AA21-555FAF8C2305Q39640672-34EDD234-E1F9-4B22-8E41-926F0497DB46Q41846032-07A80D47-1B8A-4769-86C6-1DDE6B2D7E05Q42005326-978F121A-5857-404D-B481-8D0272F4274EQ42011307-C656A2A1-46E9-42D0-B98D-212FAC3F3C64Q42142377-FD580A31-C182-43D3-A1BD-AED11B3A75BAQ43502186-5FC48DE7-C0AF-4A14-98C3-1843029F7C96Q47098255-B263CC20-D5D9-4C92-82A1-D09BF6B5B5EFQ48094614-838685ED-F7E1-4C96-8C09-0484C1DAC6D8Q48103612-E5B3F000-98B4-436A-9820-ED686DBCE723Q49216178-A66D27F6-5500-44F0-84BA-F269000F18B3
P2860
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
@en
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
@nl
type
label
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
@en
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
@nl
prefLabel
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
@en
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
@nl
P2860
P1476
N-acetylcysteine inhibits alveolar epithelial-mesenchymal transition.
@en
P2093
B C Willis
V M Felton
P2860
P304
P356
10.1152/AJPLUNG.00009.2009
P50
P577
2009-07-31T00:00:00Z